Thanks SoT,
"The pharmaceutical companies decided that if it is not a kinase and it is not a cell surface molecule, then it is 'undruggable.'
Which is why the pioneering work with IMB in Targeting the Undruggable project is so exciting. "We have now entered a new technology era that enables us to validate a novel type of molecular target that was previously considered beyond reach of any drug discovery pipeline," said Dr Francois.
How long will Big Pharma sit on the sidelines? I note from the most recent investor presentation that early 2015 should see in vitro data available with an early stage partnering opportunity. I suspect that the opportunity is not some hollow hope but based upon genuine and ongoing negotiations.
PYC Price at posting:
1.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)